The antibody has an effect of inhibiting the function of TWEAK. It is useful in the prevention or treatment of various diseases, such as systemic lupus erythematosus.
Figure 1 Growth of human pancreatic tumor cell line BXPc-3 in a xenograft animal model, with and without anti-Tweak antibody (P2D10) treatment.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-178 | Anti-Human TWEAK receptor Recombinant Antibody (Enavatuzumab) | ELISA, FC, IP, FuncS, IF, Neut, ICC | IgG1 - kappa |
TAB-217CQ-S(P) | Anti-Human TNFSF12 Recombinant Antibody scFv Fragment (huP2D10-2) | ELISA, FC, Neut | Humanized antibody |
TAB-217CQ-F(E) | Anti-Human TNFSF12 Recombinant Antibody Fab Fragment (huP2D10-2) | ELISA, FC, Neut | Humanized antibody |
There are currently no Customer reviews or questions for TAB-217CQ. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.